Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Duhay Francis | Sep 11, 2026 | Sell | $123.31 | 11 |
| Director | Duhay Francis | Jun 11, 2026 | Sell | $1.44K | 140 |
| Director | Duhay Francis | Mar 12, 2026 | Sell | $1.61K | 140 |
| Director | Duhay Francis | Dec 11, 2025 | Sell | $1.74K | 4,900 |
| Director | Duhay Francis | Sep 15, 2025 | Sell | $4.07K | 4,900 |
| Director | Gray Robert | Dec 31, 2024 | Buy | $10.29K | 3,500 |
| Director | Duhay Francis | Dec 31, 2024 | Buy | $250K | 81,433 |
| Director | Shrivastava Sanjay | Dec 24, 2024 | Buy | $15.66K | 5,400 |
| Director | Jenusaitis Matthew | Dec 19, 2024 | Buy | $24.34K | 9,620 |
| CEO | BERMAN ROBERT ANDREW | Dec 19, 2024 | Buy | $30.6K | 12,000 |
| Chief Technology Officer | Alavi Hamed | Mar 13, 2024 | Sell | $51.84K | 8,334 |
| Director | Duhay Francis | Aug 16, 2022 | Buy | $47.59K | 7,751 |
| Director | Shrivastava Sanjay | Jun 30, 2022 | Buy | $3.85K | 1,000 |
| CEO | BERMAN ROBERT ANDREW | Jun 27, 2022 | Buy | $9.5K | 2,500 |
| CEO | BERMAN ROBERT ANDREW | Nov 19, 2021 | Buy | $14.86K | 2,000 |
| CEO | BERMAN ROBERT ANDREW | Nov 16, 2021 | Buy | $15.74K | 2,000 |
| Director | Jenusaitis Matthew | Aug 25, 2021 | Buy | $10.01K | 1,300 |
| Director | Gray Robert | Jun 16, 2021 | Buy | $12.5K | 2,000 |
| SVP & Chief Medical Officer | Glickman Marc H. | May 21, 2021 | Buy | $9.44K | 1,600 |
| CEO | BERMAN ROBERT ANDREW | May 18, 2021 | Buy | $16.41K | 3,000 |
| Director | Duhay Francis | May 17, 2021 | Buy | $50.59K | 9,492 |
| Insider | Biodyne Holding, S.A. | Aug 21, 2020 | Sell | $28.5K | 75,000 |
| Insider | Biodyne Holding, S.A. | Aug 20, 2020 | Sell | $20.25K | 75,000 |
| Insider | Biodyne Holding, S.A. | Aug 19, 2020 | Sell | $15K | 50,000 |
| Insider | Biodyne Holding, S.A. | Aug 18, 2020 | Sell | $17K | 50,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.